Company

Zentalis Pharmaceuticals, Inc.

ZNTL · CIK 0001725160

SEC FORM 4

$21,204.86

Acquisition (code A) of 9,727 shares at $2.18 per share.

Reporting Person Bruns Ingmar · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001628280-26-064317 · filed 2026-10-01 · View filing →

SEC FORM 4

$15,172,500.00

Purchase of 4,335,000 shares at $3.5 per share.

Reporting Persons WALTERS GROUP · WALTERS WILLIAM THURMAN · WALTERS SUSAN BERKLEY · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 19, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001213900-26-091823 · filed 2026-08-19 · View filing →